Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-PAZOPANIB | 200MG | TABLET | Resolved | 2023-05-29 | 2023-10-16 | 193291 |
| PMS-PERINDOPRIL | 2MG | TABLET | Resolved | 2018-10-03 | 2018-10-18 | 63123 |
| PMS-PERINDOPRIL | 4MG | TABLET | Resolved | 2018-10-03 | 2018-11-29 | 63126 |
| PMS-PIOGLITAZONE | 15MG | TABLET | Resolved | 2018-04-20 | 2020-06-10 | 46728 |
| PMS-PIOGLITAZONE | 30MG | TABLET | Resolved | 2018-04-20 | 2020-06-10 | 46731 |
| PMS-PIRFENIDONE | 267MG | TABLET | Actual shortage | 2024-06-05 | 2025-03-17 | 229695 |
| PMS-PIRFENIDONE | 267MG | TABLET | Actual shortage | 2024-06-05 | 2025-03-17 | 229699 |
| PMS-PIRFENIDONE | 801MG | TABLET | Actual shortage | 2024-06-05 | 2025-03-17 | 229702 |
| PMS-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2017-12-07 | 2020-06-09 | 32074 |
| PMS-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2017-12-07 | 2020-06-09 | 32077 |
| PMS-PRAMIPEXOLE | 0.50MG | TABLET | Resolved | 2018-04-20 | 2020-06-09 | 46734 |
| PMS-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-12-07 | 2018-04-19 | 32080 |
| PMS-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-12-07 | 2018-05-05 | 32083 |
| PMS-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-11-11 | 2023-04-06 | 174387 |
| PMS-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-07-10 | 2024-08-23 | 232608 |
| PMS-PRAVASTATIN | 10MG | TABLET | Resolved | 2018-09-19 | 2018-11-29 | 61885 |
| PMS-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-03-24 | 2020-06-10 | 4271 |
| PMS-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-24 | 2018-06-29 | 4274 |
| PMS-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-24 | 2020-06-10 | 4278 |
| PMS-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-18 | 2017-10-28 | 10668 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CELECOXIB | 200MG | CAPSULE | Discontinued | 2022-08-18 | 2022-08-18 | 166951 |
| PMS-CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-11-16 | 2021-11-16 | 149397 |
| PMS-CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-11-16 | 2021-11-16 | 149394 |
| PMS-CELECOXIB | 200MG | CAPSULE | Discontinued | 2022-08-18 | 2022-08-18 | 166948 |
| PMS-CHLORAL HYDRATE SYRUP 100MG/ML | 100MG | SYRUP | Discontinued | 2018-08-24 | 2018-08-25 | 59103 |
| PMS-CHLORAL HYDRATE SYRUP 100MG/ML | 500MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149409 |
| PMS-CILAZAPRIL | 1.0MG | TABLET | Discontinued | 2020-04-02 | 2022-01-18 | 110517 |
| PMS-CILAZAPRIL | 1.0MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111063 |
| PMS-CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111069 |
| PMS-CILAZAPRIL | 5.0MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111072 |
| PMS-CILAZAPRIL | 5.0MG | TABLET | Discontinued | 2020-04-06 | 2021-10-27 | 111075 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204854 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-10-13 | 2023-10-13 | 206973 |
| PMS-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2023-10-13 | 2023-10-13 | 206970 |
| PMS-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204849 |
| PMS-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117772 |
| PMS-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2023-05-10 | 2023-05-11 | 192157 |
| PMS-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2023-05-10 | 2023-05-11 | 192160 |
| PMS-CLOBAZAM | 10MG | TABLET | Discontinued | 2020-06-16 | 2020-06-16 | 118002 |
| PMS-CLOBETASOL | 0.05% | OINTMENT | Discontinued | 2017-04-20 | 2017-05-03 | 7540 |